A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025PhotoPharmics secures $6 million to advance its home-based Celeste device
Join the club for FREE to access the whole archive and other member benefits.
PhotoPharmics secures $6 million to advance its home-based Celeste device
It avoids common delivery problems and enters Phase 1 trials in 2025
New research reveals how Parkin, PINK1, and OMA1 act as guardians of cellular energy centres
A nanoparticle-based treatment restores neurons and clears toxic proteins using near-infrared light
The Dutch startup is using ion channel research and advanced tech to develop new treatments
Click on resource name for more details.
This volume has long prevailed as one of the leading resources on Parkinson's disease edited by Rajesh Pahwa
Non-profit organisation focused on the health and welfare of people living with Parkinson's disease
No blog posts found!